News
Rusan Pharma’s 2baconil launches Anthem-Led “2baconil Kar, Zindagi Fulfil Kar” campaign on World No Tobacco Day 2025: Our ...
IDMA appoints Nikkhil K Masurkar as vice chairperson of R&D and Innovation Committee: Our Bureau, Mumbai Friday, May 30, 2025 ...
Telangana IDMA elects KV Rambabu of Pulse Pharma as president, Sekhar Rao of TherDose Pharma new secretary: Our Bureau, ...
Auron Announces begins patient dosing in phase 1 trial of AUTX-703 in advanced hematologic malignancies: Newton, Massachusetts Friday, May 30, 2025, 18:00 Hrs [IST] Auron Therapeu ...
ICMR releases two books on Indian Medicinal Plants for drug development and valuable in regulatory submissions: Our Bureau, Bengaluru Friday, May 30, 2025, 16:15 Hrs [IST] Indian ...
WHO, Africa CDC & RKI expand unique partnership to strengthen collaborative surveillance in Africa: Geneva Friday, May 30, 2025, 17:00 Hrs [IST] The World Health Organization (WHO ...
Eton Pharmaceuticals’ NDA for Khindivi receives US FDA nod for oral solution formulation: Deer Park, Illinois Friday, May 30, 2025, 13:00 Hrs [IST] Eton Pharmaceuticals, Inc, an ...
Hyderabad-based Natco Pharma has reported a profit after tax (PAT) growth of 5 per cent at Rs. 406 crore during the quarter ended March 31, 2025, as compared to Rs. 386.3 crore during the same period ...
Sir H N Reliance Foundation Hospital launches South Asia’s first Genius AI 3D Mammography System: Our Bureau, Mumbai Friday, May 30, 2025, 15:50 Hrs [IST] In a pioneering advanc ...
US FDA grants priority review status to Bayer’s sevabertinib to treat patients with HER2-mutant non-small cell lung cancer: Berlin Friday, May 30, 2025, 16:00 Hrs [IST] Bayer an ...
Our Bureau, New Delhi Friday, May 30, 2025, 14:15 Hrs [IST] Alkem Laboratories has reported a growth of 6 per cent in ...
GSK & Spero Therapeutics announce PIVOT-PO phase III study for tebipenem HBr stopped early for efficacy following review by IDMC: London, UK Friday, May 30, 2025, 15:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results